Table 1 Treated animal grouping and description.
Groups | Group name | Treatment description |
|---|---|---|
I | Normal control | Mice were fed a normal diet and 3 mL of distilled water orally for 8 weeks |
II | PCOS-induced group [HFD + Letrozole (90 µg /kg.b.w.)] | Received HFD for 8 weeks21 and given letrozole by gavage (90 µg/kg.b.w) daily for the last 3 weeks22. The dosage of letrozole (90 µg/kg b.w.) used to induce PCOS in mice is based on the protocol established by Kafali et al.,22which reliably reproduces PCOS-like ovarian cysts and hormonal disturbances in rodents. |
III | PCOS + MTF (500 mg/kg.b.w) | Given HFD for 8 weeks + Letrozole by gavage (90 µg/ kg.b.w) + MTF (500 mg/ kg. B.W.) suspended in distilled water daily along with letrozole for the last 3 weeks. |
IV | PCOS + MTL (500 mg/kg.b.w) | Given HFD for 8 weeks + Letrozole by gavage (90 µg/ kg.b.w) + MTL (500 mg/ kg. B.W.) suspended in distilled water daily along with letrozole for the last 3 weeks. |
V | PCOS + MVF (500 mg/kg.b.w) | Given HFD for 8 weeks + Letrozole by gavage (90 µg/ kg.b.w) + MVF (500 mg/ kg. B.W.) suspended in distilled water daily along with letrozole for the last 3 weeks. |
VI | PCOS + MVL (500 mg/kg.b.w) | Given HFD for 8 weeks + Letrozole by gavage (90 µg/ kg.b.w) + MVL (500 mg/ kg. B.W.) suspended in distilled water daily along with letrozole for the last 3 weeks. |
VII | PCOS + Metformin (300 mg/kg.b.w) | Given HFD for 8 weeks + Letrozole by gavage (90 µg/ kg.b.w) + Metformin (300 mg/kg b.w) suspended in distilled water daily along with letrozole for the last 3 weeks. The selected dose of metformin (500 mg/kg b.w.) was based on prior in vivo studies demonstrating therapeutic efficacy in improving hormonal, metabolic, and ovarian dysfunctions in PCOS animal models without inducing systemic toxicity. A comparable dose was used by Di Pietro et al. (2015)23who reported significant modulation of ovarian angiogenesis and follicular development using metformin in a letrozole-induced PCOS rat model. |